BackVera Therapeutics Overview

Vera Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for VERA.

Quarterly EBIT

-$125.13M
118.79% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$369.19M
98.61% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)